Welcome

7th wbc Welcome to the
7th World Bronchiectasis Conference

Dear Partners and Friends,

It’s a great pleasure – as Chair of the 7th World Bronchiectasis Conference 2024 - to invite you to join and contribute to the World Bronchiectasis Community meeting planned in Dundee from 4 to 6 July 2024.

James D. Chalmers

Chairman of the 7th WBC

Join us

why join us 7th World Bronchiectasis Conference

Programme

Discover our thoughtfully curated programme, exploring the latest in bronchiectasis research and treatment. A journey of knowledge awaits.

Abstracts

Submit your abstracts, each a unique voice in the expansive world of bronchiectasis. Share your insights and innovations.

Faculty

Meet our distinguished faculty, pioneers in bronchiectasis research. Their expertise is vital to the conference's discourse.

Explore

topics Explore The Topics

AATD – Alpha-1 Antitrypsin Deficiency
Aetiology & Physiopathology
(including inflammation, genomics, etc.)
Comorbidities and Overlaps
(including CF, COPD, etc.)
Epidemiology & Registries
Exacerbations
Imaging

Infections
(including ABP, Pseudomonas, Hemophilus, etc.)
NTM
PCD – Primary Ciliary Dyskinesia
Precision medicine
Respiratory Physiotherapy & Airways Clearance
Treatments and New Drugs

Chairs

chairs Chair and co-chairs

James D. Chalmers

(UK) Chairman

Stefano Aliberti

(Italy) Co-chair

Francesco Blasi

(Italy) Co-chair

Dates

dates Important dates

November 2023

+ Registrations opening

March 29th, 2024

+ Call for abstract closing

April 24th, 2024

+ Early registration deadline

May 24th – June 10th, 2024

+ Late breaking abstracts window (for poster only)

Venue

venue University of Dundee

Dalhousie Building

Old Hawkhill, Dundee DD1 5EN, United Kingdom.

Link >

Directions to the venue

In Collaboration With

7th wbc Welcome

Dear Partners and Friends,

It’s a great pleasure – as Chair of the 7th World Bronchiectasis Conference 2024 - to invite you to join and contribute to the World Bronchiectasis Community meeting planned in Dundee from 4 to 6 July 2024.

The last years have been amazing for our international community.

Basic science helped to start understanding the physiopathology mechanisms behind the disease.

EMBARC and National Registries contributed to clarify epidemiology, providing us precious insights on the natural development of the diseases, on comorbidities, on the most common management approaches in the different countries and the priorities to be set in research to improve the quality of life of patients.

The COVID-19 pandemic and the past several years of scientific progress have clearly placed respiratory tract infections at the centre of public health, clinical practice and scientific debate, helping us to provide new instruments to prevent and treat exacerbations and comorbidities.

Multidisciplinary approach, physiotherapy, precious tools to improve the patient journey, are, in some countries, well established, while in others they still have a long way to go to succeed in being included in the healthcare standard for bronchiectasis patients.

Hope for new therapies is today concrete and not too far away.

Genetics and again basic science are now helping us in starting to understand the causes behind the symptoms, providing instruments for a better approach to management and treatment.

The last years have been exciting ones but the years to come will for sure bring further evolutions and possibly revolutions in the field.

Within this exciting context, I invite you to participate and contribute to the next World Bronchiectasis Conference so to discover together what the future has in store for all of us and our patients.

Yours Sincerely,

James D. Chalmers

James D. Chalmers

Chairman of the 7th WBC